Intraoperative Hemolysis Monitoring by Real-time Point-of-care in Patients Undergoing Cardiopulmonary Bypass in Cardiac Surgery: A Single-centre Prospective Observational Study
Lorenzo Schiavoni MD , Mariapia Stifano MD , Francesca La Verde MD , Alessandro Strumia MD , Annalaura Di Pumpo MD , Domenico Sarubbi MD , Stefano Rizzo MD , Maria Cristina Conti MD , Lara Mortini MD , Rita Cataldo MD , Fabio Costa MD , Giuseppe Pascarella MD , Alessandro Rita , Elena Casali , Felice Eugenio Agrò MD , Massimiliano Carassiti MD , Alessia Mattei MD
{"title":"Intraoperative Hemolysis Monitoring by Real-time Point-of-care in Patients Undergoing Cardiopulmonary Bypass in Cardiac Surgery: A Single-centre Prospective Observational Study","authors":"Lorenzo Schiavoni MD , Mariapia Stifano MD , Francesca La Verde MD , Alessandro Strumia MD , Annalaura Di Pumpo MD , Domenico Sarubbi MD , Stefano Rizzo MD , Maria Cristina Conti MD , Lara Mortini MD , Rita Cataldo MD , Fabio Costa MD , Giuseppe Pascarella MD , Alessandro Rita , Elena Casali , Felice Eugenio Agrò MD , Massimiliano Carassiti MD , Alessia Mattei MD","doi":"10.1053/j.jvca.2025.02.048","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Hemolysis is a complication in surgical procedures requiring cardiopulmonary bypass (CPB). The primary aim of this study was to evaluate the effectiveness of the point-of-care device Hemcheck Helge V-Test, quantifying hemolysis during cardiac surgery with CPB.</div></div><div><h3>Design</h3><div>Prospective-observational study.</div></div><div><h3>Setting</h3><div>Single-center study.</div></div><div><h3>Participants</h3><div>Patients undergoing elective cardiac surgery with CPB.</div></div><div><h3>Interventions</h3><div>Blood samples of 78 patients were simultaneously collected during surgery at T0: pre-CPB; T1: at aorta clamping; T2: at 20 minutes after the CPB start; T3: at the end of CPB; and T4: at the end of surgery. Samples were analyzed by the Hemcheck Helge V-Test device, which offers a real-time assessment of hemolysis through the value of plasma-free hemoglobin (PfHb) expressed in mg/dL.</div></div><div><h3>Measurements and Main Results</h3><div>No case of hemolysis (PfHb ≥50 mg/dL) was recorded at T0. The results recorded median PfHb values at T0 = 0.5 (0-7.1) mg/dL, T1 = 3.75 (0-14.4) mg/dL; T2 = 8.25 (0.4-19.1) mg/dL, T3 = 27.5 (9.9-50) mg/dL, and T4 = 18.5 (2.4-41) mg/dL; for all T times, p-values were < 0.001. A statistically significant correlation was recorded between hemolysis values >50 mg/dL at T3 and CPB time >100 minutes (p < 0.05).</div></div><div><h3>Conclusions</h3><div>The use of Hemcheck Helge V-Test allows effective identification of hemolysis directly in the operating room, reducing wasted time for laboratory analyses. This could help the anesthesiologist, perfusionist, or cardiac surgeon address intraoperative hemolysis and its effects on organ function earlier and improve the postoperative course of patients undergoing cardiac surgery with CPB.</div></div>","PeriodicalId":15176,"journal":{"name":"Journal of cardiothoracic and vascular anesthesia","volume":"39 6","pages":"Pages 1432-1440"},"PeriodicalIF":2.3000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiothoracic and vascular anesthesia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1053077025001934","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Hemolysis is a complication in surgical procedures requiring cardiopulmonary bypass (CPB). The primary aim of this study was to evaluate the effectiveness of the point-of-care device Hemcheck Helge V-Test, quantifying hemolysis during cardiac surgery with CPB.
Design
Prospective-observational study.
Setting
Single-center study.
Participants
Patients undergoing elective cardiac surgery with CPB.
Interventions
Blood samples of 78 patients were simultaneously collected during surgery at T0: pre-CPB; T1: at aorta clamping; T2: at 20 minutes after the CPB start; T3: at the end of CPB; and T4: at the end of surgery. Samples were analyzed by the Hemcheck Helge V-Test device, which offers a real-time assessment of hemolysis through the value of plasma-free hemoglobin (PfHb) expressed in mg/dL.
Measurements and Main Results
No case of hemolysis (PfHb ≥50 mg/dL) was recorded at T0. The results recorded median PfHb values at T0 = 0.5 (0-7.1) mg/dL, T1 = 3.75 (0-14.4) mg/dL; T2 = 8.25 (0.4-19.1) mg/dL, T3 = 27.5 (9.9-50) mg/dL, and T4 = 18.5 (2.4-41) mg/dL; for all T times, p-values were < 0.001. A statistically significant correlation was recorded between hemolysis values >50 mg/dL at T3 and CPB time >100 minutes (p < 0.05).
Conclusions
The use of Hemcheck Helge V-Test allows effective identification of hemolysis directly in the operating room, reducing wasted time for laboratory analyses. This could help the anesthesiologist, perfusionist, or cardiac surgeon address intraoperative hemolysis and its effects on organ function earlier and improve the postoperative course of patients undergoing cardiac surgery with CPB.
期刊介绍:
The Journal of Cardiothoracic and Vascular Anesthesia is primarily aimed at anesthesiologists who deal with patients undergoing cardiac, thoracic or vascular surgical procedures. JCVA features a multidisciplinary approach, with contributions from cardiac, vascular and thoracic surgeons, cardiologists, and other related specialists. Emphasis is placed on rapid publication of clinically relevant material.